Cancer Immunotherapy Strategic Research Business Report 2023-2030: Improved Delivery Systems, Desire for Non-Toxic Treatments, Checkpoint Inhibitors Spur New Developments and Growth
December 04, 2024 10:55 ET
|
Research and Markets
Dublin, Dec. 04, 2024 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Cancer...
Combination Antibody Therapy Strategic Research Report 2024: Global Market Value to Reach $443 Billion by 2030 - Increased Use in Oncology Generates Demand for Multi-targeted Antibody Treatments
December 02, 2024 06:42 ET
|
Research and Markets
Dublin, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The "Combination Antibody Therapy - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
CD40 Agonists & CD40/Ligand Antagonists Pipeline Market Review 2024: Drug Code/INN, Target(s)/MoA, Class of Compound, Territory of Main Competitor, Indication(s) & R&D Stage
October 24, 2024 10:14 ET
|
Research and Markets
Dublin, Oct. 24, 2024 (GLOBE NEWSWIRE) -- The "CD40 Agonists & CD40/L Antagonists Pipeline Review" report has been added to ResearchAndMarkets.com's offering. This product provides basic...
Immune Checkpoint Inhibitors Market to hit USD 189.1 billion by 2032, says Global Market Insights Inc.
October 01, 2024 05:30 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Immune Checkpoint Inhibitors Market size reached USD 47.4 billion in 2023 and is projected to register a CAGR of 16.7% from 2024 to 2032...
Announcing the 2nd Annual ImmunoBio Series Conference: A Nexus of Biomarker Insights and Immuno-Oncology Innovations (Germany, 14th-15th October 2024)
July 12, 2024 11:05 ET
|
Research and Markets
Dublin, July 12, 2024 (GLOBE NEWSWIRE) -- The "2nd Annual ImmunoBio Series" conference has been added to ResearchAndMarkets.com's offering. Introducing the 2nd Annual ImmunoBio Series, a...
CCR8 Targeted Antibody Immunotherapy Pipeline Review 2024: An Emerging, Highly Attractive Next Generation Immuno-oncology Target
July 08, 2024 04:08 ET
|
Research and Markets
Dublin, July 08, 2024 (GLOBE NEWSWIRE) -- The "CCR8-Targeted Antibody Immunotherapy Pipeline Review" report has been added to ResearchAndMarkets.com's offering. CCR8 is an emerging, highly...
Global Oncolytic Virus Therapy Industry Research 2024-2032: Strategic Collaborations to Increase Market Share, Oncolytic Wild-type Viruses Driving Therapeutic Innovation, North America Leads
June 27, 2024 06:03 ET
|
Research and Markets
Dublin, June 27, 2024 (GLOBE NEWSWIRE) -- The "Global Oncolytic Virus Therapy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies...
Malignant Mesothelioma Pipeline Landscape Analysis, 2024 - Incyte's INCB001158 and Polaris' Pegargiminase Lead the Way in Mechanism-Specific Interventions
June 07, 2024 09:19 ET
|
Research and Markets
Dublin, June 07, 2024 (GLOBE NEWSWIRE) -- The "Malignant Mesothelioma - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. A comprehensive report has been...
World Immuno-Oncology Diagnostics Market Forecasts Report 2024: The Disruption Dynamic, The Race for Biomarkers, The Next Five Years
May 28, 2024 09:06 ET
|
Research and Markets
Dublin, May 28, 2024 (GLOBE NEWSWIRE) -- The "Market Forecasts for Immuno-Oncology Diagnostics Including Executive/Consultant Guides and Customized Forecasting/Analysis" report has been added to ...
Histone Deacetylase 6 Drug Pipeline Research Report 2024: Comprehensive Insights about 20+ Companies and 26+ Pipeline Drugs
April 12, 2024 10:06 ET
|
Research and Markets
Dublin, April 12, 2024 (GLOBE NEWSWIRE) -- The "Histone Deacetylase 6 - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...